Anticorps Recombinant de lapin anti-CD19
CD19 Recombinant Antibody for FC
Hôte / Isotype
Mouse / IgG2a
Réactivité testée
Humain
Applications
FC
Conjugaison
Non conjugué
CloneNo.
4G7
N° de cat : 65562-1-PBS
Synonymes
Galerie de données de validation
Informations sur le produit
65562-1-PBS cible CD19 dans les applications de FC et montre une réactivité avec des échantillons Humain
Réactivité | Humain |
Hôte / Isotype | Mouse / IgG2a |
Clonalité | Recombinant |
Type | Anticorps |
Immunogène | Cellules humaines de leucémie lymphoïde chronique (LLC) |
Nom complet | CD19 molecule |
Masse moléculaire calculée | 556 aa, 61 kDa |
Numéro d’acquisition GenBank | BC006338 |
Symbole du gène | CD19 |
Identification du gène (NCBI) | 930 |
Conjugaison | Non conjugué |
Forme | Liquide |
Méthode de purification | Protein A purfication |
Tampon de stockage | PBS only |
Conditions de stockage | Store at -80°C. Stable for one year after shipment. |
Informations générales
CD19 is a 95 kDa type I transmembrane glycoprotein belonging to the immunoglobulin superfamily (PMID: 2472450). It is expressed by B cells and follicular dendritic cells. CD19 is up-regulated at the step of B-lineage commitment during the differentiation of the hematopoietic stem cell, it remains on during subsequent stages of differentiation until finally down-regulated during terminal differentiation into plasma cells (PMID: 8528044). CD19 is involved in B cell development, activation and differentiation. It is the dominant component for the signaling complex on B cells that includes CD21 (CR2), CD81 (TAPA-1) and CD225 and acts as a critical co-receptor for BCR signal transduction (PMID: 23210908).